Neuroinflammation at the Interface of Depression and Cardiovascular Disease: Evidence from Rodent Models of Social Stress

Overview

Journal Neurobiol Stress

Date 2016 Dec 17

PMID 27981185

Citations 27

Authors

Julie E Finnell

Susan K Wood

Affiliations

Soon will be listed here.

Abstract

A large body of evidence has emerged linking stressful experiences, particularly from one's social environment, with psychiatric disorders. However, vast individual differences emerge in susceptibility to developing stress-related pathology which may be due to distinct differences in the inflammatory response to social stress. Furthermore, depression is an independent risk factor for cardiovascular disease, another inflammatory-related disease, and results in increased mortality in depressed patients. This review is focused on discussing evidence for stress exposure resulting in persistent or sensitized inflammation in one individual while this response is lacking in others. Particular focus will be directed towards reviewing the literature underlying the impact that neuroinflammation has on neurotransmitters and neuropeptides that could be involved in the pathogenesis of comorbid depression and cardiovascular disease. Finally, the theme throughout the review will be to explore the notion that stress-induced inflammation is a key player in the high rate of comorbidity between psychosocial disorders and cardiovascular disease.

Citing Articles

Association of systemic immune-inflammation index with all-cause and cardiovascular mortality among adults with depression: evidence from NHANES 2005-2018.

Yu X, Zheng H, Liu M, Wu L, Tian S, Wu W BMC Psychiatry. 2025; 25(1):25.

PMID: 39780080 PMC: 11707943. DOI: 10.1186/s12888-024-06463-y.

The extracellular vesicle of depressive patient-derived Escherichia fergusonii induces vagus nerve-mediated neuroinflammation in mice.

Ma X, Park H, Shin Y, Kim J, Hong J, Han S J Neuroinflammation. 2024; 21(1):224.

PMID: 39277768 PMC: 11402204. DOI: 10.1186/s12974-024-03211-7.

Voluntary wheel running as a promising strategy to promote autonomic resilience to social stress in females: Vagal tone lies at the heart of the matter.

Pate B, Smiley C, Harrington E, Bielicki B, Davis J, Reagan L Auton Neurosci. 2024; 253:103175.

PMID: 38677130 PMC: 11173375. DOI: 10.1016/j.autneu.2024.103175.

Mood, Behavioral Impairment, and Sleep Breathing Disorders in Obstructive Sleep Apnea Syndrome Patients Treated with Maxillomandibular Advancement: Reflection on a Case Series and Review of Literature.

Stilo G, Lo Faro C, Pollicina I, Falcone L, Campagna P, Felis S J Pers Med. 2023; 13(10).

PMID: 37888036 PMC: 10607968. DOI: 10.3390/jpm13101425.

Chronic social defeat alters brain vascular-associated cell gene expression patterns leading to vascular dysfunction and immune system activation.

Samuels J, Lotstein M, Lehmann M, Elkahloun A, Banerjee S, Herkenham M J Neuroinflammation. 2023; 20(1):154.

PMID: 37380974 PMC: 10303797. DOI: 10.1186/s12974-023-02827-5.

References

Chen Y, Huang Z . Stimulation of locus coeruleus increases arterial pressure in rabbits. Zhongguo Yao Li Xue Bao. 1999; 18(5):437-40. View

Buwalda B, de Boer S, Schmidt E, Felszeghy K, Nyakas C, Sgoifo A . Long-lasting deficient dexamethasone suppression of hypothalamic-pituitary-adrenocortical activation following peripheral CRF challenge in socially defeated rats. J Neuroendocrinol. 1999; 11(7):513-20. DOI: 10.1046/j.1365-2826.1999.00350.x. View

Haller J, Fuchs E, Halasz J, Makara G . Defeat is a major stressor in males while social instability is stressful mainly in females: towards the development of a social stress model in female rats. Brain Res Bull. 1999; 50(1):33-9. DOI: 10.1016/s0361-9230(99)00087-8. View

Koolhaas J, Korte S, de Boer S, van der Vegt B, van Reenen C, Hopster H . Coping styles in animals: current status in behavior and stress-physiology. Neurosci Biobehav Rev. 1999; 23(7):925-35. DOI: 10.1016/s0149-7634(99)00026-3. View

Wong M, Kling M, Munson P, Listwak S, Licinio J, Prolo P . Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: relation to hypercortisolism and corticotropin-releasing hormone. Proc Natl Acad Sci U S A. 2000; 97(1):325-30. PMC: 26662. DOI: 10.1073/pnas.97.1.325. View

Nijsen M, Croiset G, Stam R, Bruijnzeel A, Diamant M, de Wied D . The role of the CRH type 1 receptor in autonomic responses to corticotropin- releasing hormone in the rat. Neuropsychopharmacology. 2000; 22(4):388-99. DOI: 10.1016/S0893-133X(99)00126-8. View

Manna S, Mukhopadhyay A, Aggarwal B . Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-kappa B, activator protein-1, and apoptosis: potential role of reactive oxygen intermediates and lipid peroxidation. J Immunol. 2000; 164(12):6509-19. DOI: 10.4049/jimmunol.164.12.6509. View

Miczek K . A new test for aggression in rats without aversive stimulation: differential effects of d-amphetamine and cocaine. Psychopharmacology (Berl). 1979; 60(3):253-9. DOI: 10.1007/BF00426664. View

Lacosta S, Merali Z, Anisman H . Central monoamine activity following acute and repeated systemic interleukin-2 administration. Neuroimmunomodulation. 2000; 8(2):83-90. DOI: 10.1159/000026457. View

10.

Briscoe R, Cabrera C, Baird T, Rice K, Woods J . Antalarmin blockade of corticotropin releasing hormone-induced hypertension in rats. Brain Res. 2000; 881(2):204-7. DOI: 10.1016/s0006-8993(00)02742-6. View

11.

Cohen H, GIBSON G, Alderman M . Excess risk of myocardial infarction in patients treated with antidepressant medications: association with use of tricyclic agents. Am J Med. 2000; 108(1):2-8. DOI: 10.1016/s0002-9343(99)00301-0. View

12.

Ye S, Mozayeni P, Gamburd M, Zhong H, Campese V . Interleukin-1beta and neurogenic control of blood pressure in normal rats and rats with chronic renal failure. Am J Physiol Heart Circ Physiol. 2000; 279(6):H2786-96. DOI: 10.1152/ajpheart.2000.279.6.H2786. View

13.

Ressler K, Nemeroff C . Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders. Depress Anxiety. 2000; 12 Suppl 1:2-19. DOI: 10.1002/1520-6394(2000)12:1+<2::AID-DA2>3.0.CO;2-4. View

14.

Musselman D, Lawson D, Gumnick J, Manatunga A, Penna S, Goodkin R . Paroxetine for the prevention of depression induced by high-dose interferon alfa. N Engl J Med. 2001; 344(13):961-6. DOI: 10.1056/NEJM200103293441303. View

15.

Kendler K, Thornton L, Prescott C . Gender differences in the rates of exposure to stressful life events and sensitivity to their depressogenic effects. Am J Psychiatry. 2001; 158(4):587-93. DOI: 10.1176/appi.ajp.158.4.587. View

16.

Sgoifo A, Pozzato C, Costoli T, Manghi M, Stilli D, Ferrari P . Cardiac autonomic responses to intermittent social conflict in rats. Physiol Behav. 2001; 73(3):343-9. DOI: 10.1016/s0031-9384(01)00455-3. View

17.

Musselman D, Miller A, PORTER M, Manatunga A, Gao F, Penna S . Higher than normal plasma interleukin-6 concentrations in cancer patients with depression: preliminary findings. Am J Psychiatry. 2001; 158(8):1252-7. DOI: 10.1176/appi.ajp.158.8.1252. View

18.

Zou C, Liu J, Zhou Y . Roles of central interleukin-1 on stress-induced-hypertension and footshock-induced-analgesia in rats. Neurosci Lett. 2001; 311(1):41-4. DOI: 10.1016/s0304-3940(01)02140-1. View

19.

Capuron L, Ravaud A, Gualde N, Bosmans E, Dantzer R, Maes M . Association between immune activation and early depressive symptoms in cancer patients treated with interleukin-2-based therapy. Psychoneuroendocrinology. 2001; 26(8):797-808. DOI: 10.1016/s0306-4530(01)00030-0. View

20.

Falchetti R, Fuggetta M, Lanzilli G, Tricarico M, Ravagnan G . Effects of resveratrol on human immune cell function. Life Sci. 2002; 70(1):81-96. DOI: 10.1016/s0024-3205(01)01367-4. View